Medications recommended for chronic heart failure with reduced ejection fraction (HFrEF) continue to be underused, according to findings from a Dutch registry study.

Adherence to the European Society of Cardiology (ESC)’s drug-therapy guidelines was examined in more than 10,900 patients enrolled in the CHECK-HF registry in the study, led by Dr Hans-Peter Brunner-La Rocca from Maastricht University Medical Centre.